13148_2021_1006_MOESM1_ESM.pdf (457.56 kB)
Additional file 1 of CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients
journal contribution
posted on 2021-01-23, 04:33 authored by Karolin Heinze, Matthias Rengsberger, Mieczyslaw Gajda, Lars Jansen, Linea Osmers, Leticia Oliveira-Ferrer, Barbara Schmalfeldt, Matthias Dürst, Norman Häfner, Ingo B. RunnebaumAdditional file 1: Figure S1. Graphical overview of methylations-specific PCR validation results. Figure S2. Kaplan–Meier plots for PFS and OS of EOC patients stratified by clinical variables. Figure S3. Comparison of methylation frequency in tumors with different tumor cell fraction. Table S1. Clinical data and mutation data of EOC with known mutations (n = 15). Table S2. Primer data for MSP and BRCA1 mutation analysis. Table S3. BRCA1 immunohistochemistry results for a subset of tumors depending on BRCA1 aberrations.
